These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration. Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH J Pharmacol Exp Ther; 1997 Apr; 281(1):129-35. PubMed ID: 9103489 [TBL] [Abstract][Full Text] [Related]
3. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs. Gué M; Junien JL; Bueno L J Pharmacol Exp Ther; 1989 Sep; 250(3):1006-10. PubMed ID: 2550612 [TBL] [Abstract][Full Text] [Related]
4. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells. Baumhaker Y; Gafni M; Keren O; Sarne Y Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999 [TBL] [Abstract][Full Text] [Related]
5. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites. Jiang Q; Sheldon RJ; Porreca F J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010 [TBL] [Abstract][Full Text] [Related]
6. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex. Werling LL; McMahon PN; Cox BM J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse. Tseng LF; Collins KA J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues. Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345 [TBL] [Abstract][Full Text] [Related]
10. Lack of relationship between opioid-induced changes in fetal breathing and plasma glucose levels. Szeto HH; Cheng PY; Soong Y; Wu DL Am J Physiol; 1995 Sep; 269(3 Pt 2):R702-7. PubMed ID: 7573573 [TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. Wells JL; Bartlett JL; Ananthan S; Bilsky EJ J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048 [TBL] [Abstract][Full Text] [Related]
12. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse. Porreca F; Burks TF J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019 [TBL] [Abstract][Full Text] [Related]
13. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum. Capasso A; Sorrentino L Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209 [TBL] [Abstract][Full Text] [Related]
14. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. Kest B; McLemore G; Kao B; Inturrisi CE J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. Mitrovic I; Napier TC J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342 [TBL] [Abstract][Full Text] [Related]
16. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. Tao R; Auerbach SB J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635 [TBL] [Abstract][Full Text] [Related]
17. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay. Sterious SN; Walker EA J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605 [TBL] [Abstract][Full Text] [Related]
18. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. Cahill CM; White TD; Sawynok J J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600 [TBL] [Abstract][Full Text] [Related]
19. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. Stewart PE; Hammond DL J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. Machelska H; Labuz D; Przewłocki R; Przewłocka B J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]